Literature DB >> 28884921

Survival beyond the perinatal period expands the phenotypes caused by mutations in GLE1.

Edith Said1,2, Jessica X Chong3, Maja Hempel4, Jonas Denecke5, Paul Soler6, Tim Strom7,8, Deborah A Nickerson9, Christian Kubisch5, Michael J Bamshad3,9,10, Davor Lessel4.   

Abstract

Mutations in GLE1 underlie Lethal Congenital Contracture syndrome (LCCS) and Lethal Arthrogryposis with Anterior Horn Cell Disease (LAAHD). Both LCCS and LAAHD are characterized by reduced fetal movements, congenital contractures, and a severe form of motor neuron disease that results in fetal death or death in the perinatal period, respectively. We identified bi-allelic mutations in GLE1 in two unrelated individuals with motor delays, feeding difficulties, and respiratory insufficiency who survived beyond the perinatal period. Each affected child had missense variants predicted to result in amino acid substitutions near the C-terminus of GLE1 that are predicted to disrupt protein-protein interaction or GLE1 protein targeting. We hypothesize that mutations that preserve function of the coiled-coil domain of GLE1 cause LAAHD whereas mutations that abolish the function of the coiled-coil domain cause LCCS. The phenotype of LAAHD is now expanded to include multiple individuals surviving into childhood suggesting that LAAHD is a misnomer and should be re-named Arthrogryposis with Anterior Horn Cell Disease (AAHD).
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  GLE1; arthrogryposis; developmental delay; motor neuron disease; phenotype expansion; respiratory difficulties

Mesh:

Substances:

Year:  2017        PMID: 28884921      PMCID: PMC5659324          DOI: 10.1002/ajmg.a.38406

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  18 in total

1.  De Novo Mutations in CHAMP1 Cause Intellectual Disability with Severe Speech Impairment.

Authors:  Maja Hempel; Kirsten Cremer; Charlotte W Ockeloen; Klaske D Lichtenbelt; Johanna C Herkert; Jonas Denecke; Tobias B Haack; Alexander M Zink; Jessica Becker; Eva Wohlleber; Jessika Johannsen; Bader Alhaddad; Rolph Pfundt; Sigrid Fuchs; Dagmar Wieczorek; Tim M Strom; Koen L I van Gassen; Tjitske Kleefstra; Christian Kubisch; Hartmut Engels; Davor Lessel
Journal:  Am J Hum Genet       Date:  2015-09-03       Impact factor: 11.025

Review 2.  The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities.

Authors:  Jessica X Chong; Kati J Buckingham; Shalini N Jhangiani; Corinne Boehm; Nara Sobreira; Joshua D Smith; Tanya M Harrell; Margaret J McMillin; Wojciech Wiszniewski; Tomasz Gambin; Zeynep H Coban Akdemir; Kimberly Doheny; Alan F Scott; Dimitri Avramopoulos; Aravinda Chakravarti; Julie Hoover-Fong; Debra Mathews; P Dane Witmer; Hua Ling; Kurt Hetrick; Lee Watkins; Karynne E Patterson; Frederic Reinier; Elizabeth Blue; Donna Muzny; Martin Kircher; Kaya Bilguvar; Francesc López-Giráldez; V Reid Sutton; Holly K Tabor; Suzanne M Leal; Murat Gunel; Shrikant Mane; Richard A Gibbs; Eric Boerwinkle; Ada Hamosh; Jay Shendure; James R Lupski; Richard P Lifton; David Valle; Deborah A Nickerson; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2015-07-09       Impact factor: 11.025

3.  Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test.

Authors:  J Thevenon; Y Duffourd; A Masurel-Paulet; M Lefebvre; F Feillet; S El Chehadeh-Djebbar; J St-Onge; A Steinmetz; F Huet; M Chouchane; V Darmency-Stamboul; P Callier; C Thauvin-Robinet; L Faivre; J B Rivière
Journal:  Clin Genet       Date:  2016-04-26       Impact factor: 4.438

4.  The Matchmaker Exchange: a platform for rare disease gene discovery.

Authors:  Anthony A Philippakis; Danielle R Azzariti; Sergi Beltran; Anthony J Brookes; Catherine A Brownstein; Michael Brudno; Han G Brunner; Orion J Buske; Knox Carey; Cassie Doll; Sergiu Dumitriu; Stephanie O M Dyke; Johan T den Dunnen; Helen V Firth; Richard A Gibbs; Marta Girdea; Michael Gonzalez; Melissa A Haendel; Ada Hamosh; Ingrid A Holm; Lijia Huang; Matthew E Hurles; Ben Hutton; Joel B Krier; Andriy Misyura; Christopher J Mungall; Justin Paschall; Benedict Paten; Peter N Robinson; François Schiettecatte; Nara L Sobreira; Ganesh J Swaminathan; Peter E Taschner; Sharon F Terry; Nicole L Washington; Stephan Züchner; Kym M Boycott; Heidi L Rehm
Journal:  Hum Mutat       Date:  2015-10       Impact factor: 4.878

5.  Interaction between the shuttling mRNA export factor Gle1 and the nucleoporin hCG1: a conserved mechanism in the export of Hsp70 mRNA.

Authors:  Frederic Kendirgi; Deborah J Rexer; Abel R Alcázar-Román; Halina M Onishko; Susan R Wente
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

6.  GeneMatcher: a matching tool for connecting investigators with an interest in the same gene.

Authors:  Nara Sobreira; François Schiettecatte; David Valle; Ada Hamosh
Journal:  Hum Mutat       Date:  2015-08-13       Impact factor: 4.878

7.  The human homologue of Saccharomyces cerevisiae Gle1p is required for poly(A)+ RNA export.

Authors:  J L Watkins; R Murphy; J L Emtage; S R Wente
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

8.  Expansion of the GLE1-associated arthrogryposis multiplex congenita clinical spectrum.

Authors:  C Smith; J S Parboosingh; K M Boycott; C G Bönnemann; J K Mah; R E Lamont; A Micheil Innes; F P Bernier
Journal:  Clin Genet       Date:  2017-01-30       Impact factor: 4.438

9.  Gle1 functions during mRNA export in an oligomeric complex that is altered in human disease.

Authors:  Andrew W Folkmann; Scott E Collier; Xiaoyan Zhan; Melanie D Ohi; Susan R Wente
Journal:  Cell       Date:  2013-10-24       Impact factor: 41.582

10.  An essential role for hGle1 nucleocytoplasmic shuttling in mRNA export.

Authors:  Frederic Kendirgi; Dianne M Barry; Eric R Griffis; Maureen A Powers; Susan R Wente
Journal:  J Cell Biol       Date:  2003-03-31       Impact factor: 10.539

View more
  5 in total

1.  Pathogenic variants in nucleoporin TPR (translocated promoter region, nuclear basket protein) cause severe intellectual disability in humans.

Authors:  Nicole J Van Bergen; Katrina M Bell; Kirsty Carey; Russell Gear; Sean Massey; Edward K Murrell; Lyndon Gallacher; Kate Pope; Paul J Lockhart; Andrew Kornberg; Lynn Pais; Marzena Walkiewicz; Cas Simons; Vihandha O Wickramasinghe; Susan M White; John Christodoulou
Journal:  Hum Mol Genet       Date:  2022-02-03       Impact factor: 5.121

Review 2.  Pena-Shokeir syndrome: current management strategies and palliative care.

Authors:  Sumaiya Adam; Melantha Coetzee; Engela Magdalena Honey
Journal:  Appl Clin Genet       Date:  2018-10-25

3.  Genetic analysis of ALS cases in the isolated island population of Malta.

Authors:  Rebecca Borg; Maia Farrugia Wismayer; Karl Bonavia; Andrew Farrugia Wismayer; Malcolm Vella; Joke J F A van Vugt; Brendan J Kenna; Kevin P Kenna; Neville Vassallo; Jan H Veldink; Ruben J Cauchi
Journal:  Eur J Hum Genet       Date:  2021-01-07       Impact factor: 4.246

4.  Population-level deficit of homozygosity unveils CPSF3 as an intellectual disability syndrome gene.

Authors:  Gudny A Arnadottir; Asmundur Oddsson; Brynjar O Jensson; Svanborg Gisladottir; Mariella T Simon; Asgeir O Arnthorsson; Hildigunnur Katrinardottir; Run Fridriksdottir; Erna V Ivarsdottir; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Rebekah Barrick; Jona Saemundsdottir; Louise le Roux; Gudjon R Oskarsson; Jurate Asmundsson; Thora Steffensen; Kjartan R Gudmundsson; Petur Ludvigsson; Jon J Jonsson; Gisli Masson; Ingileif Jonsdottir; Hilma Holm; Jon G Jonasson; Olafur Th Magnusson; Olafur Thorarensen; Jose Abdenur; Gudmundur L Norddahl; Daniel F Gudbjartsson; Hans T Bjornsson; Unnur Thorsteinsdottir; Patrick Sulem; Kari Stefansson
Journal:  Nat Commun       Date:  2022-02-04       Impact factor: 17.694

5.  Extension of the phenotypic spectrum of GLE1-related disorders to a mild congenital form resembling congenital myopathy.

Authors:  Mathieu Cerino; Chloé Di Meglio; Francesca Albertini; Frédérique Audic; Florence Riccardi; Christophe Boulay; Nicole Philip; Marc Bartoli; Nicolas Lévy; Martin Krahn; Brigitte Chabrol
Journal:  Mol Genet Genomic Med       Date:  2020-06-14       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.